InvestorsHub Logo
Followers 33
Posts 2678
Boards Moderated 0
Alias Born 10/28/2013

Re: Doktornolittle post# 18854

Wednesday, 09/23/2015 3:22:30 PM

Wednesday, September 23, 2015 3:22:30 PM

Post# of 480569
I shouldn't say they bought all of their drugs. They did have a research group. Dr. Vamvakides was in charge. Dr. Vamvakides or Vamvakides and Dr. Maurice came up with the synegistic Anavex 2-73 plus. That is their front runner drug at the moment. They did not design the components. One they bought and the other is a generic in common use for Alzheimer's, but they did develope the synergistic combination. Apparently such are patentable if they exhibit "special synergy". That is to say: patentable seperate from a patent on Anavex 2-73.

I don't remember if any of their other drugs were developed in house.

Vamvakides is now retired.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News